Dr. Kevin Fenton
Kevin has worked in a variety of public health roles across government and academia in the UK and internationally.
He became London’s PHE Regional Director of Public Health and NHS in April 2020. He is the statutory public health advisor to the Mayor of London. He provides leadership across London for health, prevention of ill health, health protection and reduction of health inequalities.
In November 2020, Kevin was named by Powerlist as the second most influential black person in Britain for his work leading the fight against coronavirus and his public health leadership on tackling inequalities.
In Spring 2020, he oversaw the national PHE review of disparities in risks and outcomes of COVID-19 which included an epidemiological investigation, rapid review of the published literature, and an extensive stakeholder engagement with BAME communities, professionals, faith and system leaders. The review led to seven key recommendations which have shaped a more equitable COVID-19 pandemic response, nationally and locally.
Prior to starting as London’s Regional Director he held a joint position as Strategic Director of Place and Wellbeing and Director of Public Health at London Borough of Southwark, and Senior Advisor, Public Health England. In this role he led the council’s planning, regeneration, community engagement and public health portfolios driving inclusive regeneration, digital public health, asset-based community development and promoting health in all policies - working in partnership with NHS.
Professor Fenton was previously PHE’s National Director for Health and Wellbeing leading national prevention programmes including screening for cancer, NHS Health Checks, obesity, mental health, e-cigarettes and tobacco harm reduction, HIV, sexual and reproductive health. He also established and led PHE's Health Equity programme focused on addressing the social determinants of health and promoting place-based approaches to health improvement.
Between 2005-2012, Professor Fenton was the Director of the National Centre for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centres for Disease Control and Prevention (CDC). He also served as chief of CDC’s National Syphilis Elimination Effort and has worked in research, epidemiology, and the prevention of HIV and other STDs since 1995. Previously he was the director of the HIV and STI Department at the United Kingdom’s Health Protection Agency.